Pancreatic Surgery Practice Questions

Q: Which of the following is best for the localization of Zollinger-Ellison syndrome?

Endoscopic ultrasound (EUS). **Explanation:** Zollinger-Ellison Syndrome (ZES) is caused by a gastrin-secreting tumor (gastrinoma), typically located within the **Gastrinoma Triangle** (Passaro’s Triangle). Localization is a two-step process: biochemical diagnosis followed by anatomical localization. **1. Why Endoscopic Ultrasound (EUS) is correct:** EUS is considered the most sensitive imaging modality for localizing small gastrinomas, especially those located in the **pancreas or the duodenal wall**. It can detect lesions as small as 2–5 mm, which are often missed by conventional CT or MRI. While Somatostatin Receptor Scintigraphy (SRS/Octreoscan) or Ga-68 DOTATATE PET-CT are excellent for whole-body screening, EUS remains superior for precise regional localization and guided biopsy. **2. Why other options are incorrect:** * **Secretin Injection Test:** This is a **biochemical provocative test** used to *diagnose* ZES (a rise in serum gastrin >200 pg/mL is diagnostic). It confirms the presence of the disease but does not localize the tumor. * **Basal Gastric Acid Output (BAO):** This is a diagnostic screening tool. A BAO >15 mEq/hr is suggestive of ZES but provides no information regarding the anatomical site of the tumor. * **MRI:** While useful for detecting liver metastases, MRI has lower sensitivity than EUS or SRS for identifying small primary gastrinomas in the duodenum. **Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle Boundaries:** Junction of cystic/common bile duct, junction of 2nd and 3rd parts of the duodenum, and the neck/body of the pancreas. * **Most common site:** Historically the pancreas, but more recent studies show the **duodenum** is the most common site for primary gastrinomas. * **MEN-1 Association:** 25% of ZES cases occur as part of Multiple Endocrine Neoplasia Type 1. * **Best Initial Imaging:** Ga-68 DOTATATE PET-CT (now preferred over Octreoscan). * **Most Sensitive for Pancreatic Lesions:** EUS.

Q: A 45-year-old female presents with recurrent epigastric abdominal pain and jaundice. Ultrasound shows clusters of cysts with lobulated margins in the head of the pancreas. MRI reveals a multicystic mass with a "bunch of grapes" appearance and a grossly dilated pancreatic duct. What is the most probable diagnosis?

Intraductal papillary mucinous neoplasm (IPMN). ### Explanation The correct diagnosis is **Intraductal Papillary Mucinous Neoplasm (IPMN)**. **1. Why IPMN is correct:** The key diagnostic features in this clinical vignette are the **"bunch of grapes"** appearance and the **grossly dilated pancreatic duct**. IPMNs are mucin-producing epithelial neoplasms that arise within the main pancreatic duct or its side branches. * **Main-duct IPMN:** Characterized by segmental or diffuse dilation of the main pancreatic duct (>5 mm). * **Side-branch IPMN:** Presents as a multicystic lesion (the "bunch of grapes") communicating with the duct. The presence of jaundice suggests involvement of the pancreatic head, potentially causing biliary obstruction. **2. Why other options are incorrect:** * **Serous Cystadenoma:** Typically presents with a "honeycomb" appearance and a **central stellate scar** with calcification. It does not communicate with or cause gross dilation of the pancreatic duct. * **Mucinous Cystadenoma:** Usually occurs in the **body or tail** of the pancreas in middle-aged women. It consists of large, unilocular or macrocystic lesions (usually <6 cysts) and lacks ductal communication. * **Solid Pseudopapillary Epithelial Neoplasm (SPEN):** Typically seen in **young females** ("Frantz tumor"). It appears as a large, well-circumscribed mass with both solid and cystic (hemorrhagic/necrotic) components, rather than a cluster of small cysts. **3. High-Yield Clinical Pearls for NEET-PG:** * **Pathognomonic Sign:** Visualization of mucin extruding from a "fish-mouth" ampulla during ERCP is diagnostic for IPMN. * **Malignant Potential:** Main-duct IPMNs have a much higher risk of malignancy (up to 60-70%) compared to side-branch IPMNs. * **Rule of Gender:** Remember "Mother" (Mucinous - middle-aged female), "Grandmother" (Serous - elderly female), and "Daughter" (SPEN - young female). IPMN affects males and females more equally.

Q: What is the primary diagnostic investigation for carcinoma of the pancreas?

MDCT (Multidetector Computed Tomography). **Explanation:** **MDCT (Multidetector Computed Tomography)** is the gold standard and primary diagnostic investigation for pancreatic carcinoma. The "Pancreatic Protocol" CT involves thin-slice (0.5–1 mm) imaging during the late arterial and portal venous phases. It is preferred because it provides high-resolution details of the primary tumor, its relationship to major peripancreatic vessels (SMA, Celiac axis, Portal vein), and the presence of distant metastases. This allows for simultaneous diagnosis and **staging (resectability assessment)**, which is crucial for surgical planning. **Why other options are incorrect:** * **PET Scan:** While useful for detecting occult distant metastases, it lacks the anatomical detail required for local staging and resectability assessment. It is not a first-line diagnostic tool. * **ERCP:** Historically used for diagnosis, it is now primarily a **therapeutic** intervention. It is reserved for biliary drainage (stenting) in patients with obstructive jaundice or for obtaining brush cytology if the diagnosis is unclear. It is invasive and carries a risk of pancreatitis. * **MRCP:** Excellent for visualizing the biliary tree and pancreatic duct (showing the "Double Duct Sign"), but it is generally inferior to MDCT for assessing vascular invasion and overall resectability. **High-Yield Clinical Pearls for NEET-PG:** * **Double Duct Sign:** Simultaneous dilatation of the Common Bile Duct and Pancreatic Duct; highly suggestive of a head of pancreas or periampullary tumor. * **Tumor Marker:** **CA 19-9** is the most specific marker for monitoring prognosis and recurrence, but not for primary screening (as it can be elevated in benign jaundice). * **Courvoisier’s Law:** In a patient with obstructive jaundice, if the gallbladder is palpable, the obstruction is unlikely to be a stone (suggests malignancy).

Q: What is a pseudopancreatic cyst?

A cyst that develops following inflammation. ### Explanation A **pseudopancreatic cyst** (or pancreatic pseudocyst) is a localized collection of pancreatic fluid, rich in digestive enzymes, surrounded by a wall of fibrous or granulation tissue. **Why Option B is correct:** The most common etiology for a pseudocyst is **acute pancreatitis** (inflammation). Following an episode of inflammation, pancreatic ductal disruption occurs, leading to the leakage of secretions. Unlike true cysts, pseudocysts lack an epithelial lining; instead, the body walls off the fluid using adjacent organs (stomach, duodenum, or pancreas) and inflammatory fibrosis. **Analysis of Incorrect Options:** * **Option A:** While trauma can cause a pseudocyst, it is not the defining characteristic. Inflammation (from any cause, including alcohol or gallstones) is the primary pathophysiological driver. * **Option C:** Cysts present from birth are **congenital cysts** (e.g., polycystic disease or dermoid cysts), which possess a true epithelial lining. * **Option D:** Cysts that are tumors are classified as **cystic neoplasms** (e.g., Serous Cystadenoma, Mucinous Cystic Neoplasm, or IPMN). These are neoplastic growths, not inflammatory collections. **NEET-PG High-Yield Pearls:** * **Timeframe:** A pseudocyst typically takes **4–6 weeks** to form after an episode of acute pancreatitis. * **Location:** Most commonly found in the **lesser sac**. * **Diagnosis:** **CECT** is the gold standard for diagnosis and monitoring. * **Management:** Most resolve spontaneously. Intervention (e.g., endoscopic cystogastrostomy) is indicated only if the cyst is symptomatic, infected, or rapidly enlarging. * **Key Distinction:** If the collection occurs within the first 4 weeks and lacks a defined wall, it is termed an **Acute Peripancreatic Fluid Collection (APFC)**.

Q: What is the best prognosis for carcinoma of the pancreas?

Periampullary. ### Explanation The prognosis of pancreatic and peripancreatic cancers is primarily determined by the **timing of clinical presentation** and the **resectability** at the time of diagnosis. **Why Periampullary is the correct answer:** Periampullary carcinomas (which include tumors of the ampulla of Vater, distal common bile duct, and duodenum) have the **best prognosis** because they present early. Due to their anatomical location, even small tumors cause early biliary obstruction, leading to **painless progressive jaundice**. This early symptom prompts medical evaluation while the tumor is still small and localized, resulting in a higher rate of surgical resectability (Whipple’s procedure) and better 5-year survival rates (30–50%) compared to true pancreatic ductal adenocarcinoma. **Why other options are incorrect:** * **Head of Pancreas:** While these also present with jaundice, they tend to be more aggressive biologically than periampullary tumors. By the time they cause symptoms, they often involve local vessels or lymph nodes. * **Body and Tail:** These are known as the "silent killers" of the pancreas. Because they do not obstruct the bile duct early, they remain asymptomatic until they reach a large size or metastasize. They typically present with weight loss and back pain, and the majority are unresectable at the time of diagnosis, leading to the worst prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common periampullary tumor:** Carcinoma of the head of the pancreas (but it has the worst prognosis among the group). * **Best prognosis among periampullary tumors:** Ampullary carcinoma. * **Courvoisier’s Law:** In a patient with painless jaundice and a palpable gallbladder, the cause is unlikely to be gallstones (usually malignancy). * **Double Duct Sign:** Dilatation of both the common bile duct and the pancreatic duct on imaging, highly suggestive of a tumor in the head of the pancreas or ampulla.

Q: Which of the following does NOT correlate with the severity of acute pancreatitis?

Serum amylase. **Explanation:** The severity of acute pancreatitis is determined by the extent of pancreatic necrosis and the systemic inflammatory response, not by the magnitude of enzyme elevation. **1. Why Serum Amylase is the Correct Answer:** Serum amylase is a diagnostic marker, not a prognostic one. While it rises rapidly within 6–12 hours of onset, its absolute level **does not correlate** with the severity of the disease, the etiology, or the prognosis. A patient with mild edematous pancreatitis may have amylase levels >1000 U/L, while a patient with life-threatening necrotizing pancreatitis may have near-normal levels (especially in cases of hypertriglyceridemia or chronic alcohol abuse where pancreatic reserve is low). **2. Why the Other Options are Incorrect (Prognostic Markers):** The other three options are components of the **Ranson Criteria**, a classic scoring system used to predict severity at admission: * **Serum Glucose (>200 mg/dL):** Reflects endocrine pancreatic dysfunction and the severity of the systemic stress response. * **AST (>250 U/L):** Indicates hepatocellular injury often associated with biliary pancreatitis or systemic inflammatory response. * **Serum Calcium (<8 mg/dL):** Hypocalcemia occurs due to "saponification" (calcium soap formation in necrotic fat) and is a sign of severe disease. **Clinical Pearls for NEET-PG:** * **Most Specific Enzyme:** Serum Lipase (remains elevated longer than amylase). * **Best Imaging for Severity:** Contrast-Enhanced CT (CECT) scan (ideally done after 72 hours). * **Single Best Lab Marker for Prognosis:** C-Reactive Protein (CRP) >150 mg/L at 48 hours. * **Ranson’s Mnemonic (at admission):** **GAWOT** (Glucose, Age, WBC, AST, LDH).

Q: Which of the following statements is FALSE regarding intraductal papillary mucinous neoplasm?

Treatment involves the Beger's procedure.. **Explanation:** **Intraductal Papillary Mucinous Neoplasm (IPMN)** is a pre-malignant cystic lesion of the pancreas characterized by the production of thick, "fish-mouth" mucus from the Ampulla of Vater. **Why Option D is the Correct (False) Statement:** The **Beger’s procedure** (duodenum-preserving pancreatic head resection) is a surgical technique primarily indicated for **chronic pancreatitis** with an inflammatory mass in the head. It is **not** the standard treatment for IPMN. Because IPMN has a significant malignant potential, the treatment of choice is formal oncologic resection—typically a **Whipple’s procedure** (Pancreaticoduodenectomy) for lesions in the head or a **Distal Pancreatectomy** for lesions in the body/tail. **Analysis of Other Options:** * **Option A (CEA is often raised):** Analysis of cyst fluid typically shows high levels of **Carcinoembryonic Antigen (CEA)**, which helps differentiate mucinous lesions (IPMN, Mucinous Cystadenoma) from non-mucinous ones (Serous Cystadenoma). * **Option B (Amylase can be raised):** Since IPMNs communicate directly with the pancreatic ductal system, the cyst fluid contains high levels of **amylase**, unlike Mucinous Cystadenomas which do not communicate with the duct. * **Option C (Gender Distribution):** Unlike Mucinous Cystadenomas (which occur almost exclusively in females), IPMNs occur with **equal frequency in both males and females**, typically in the 6th or 7th decade of life. **High-Yield Clinical Pearls for NEET-PG:** * **"Fish-mouth" appearance** of the papilla on ERCP is pathognomonic for IPMN. * **Main-duct IPMN** has a much higher malignancy risk (>60%) compared to **Branch-duct IPMN** (~25%). * **Worrisome features** on imaging (cyst >3cm, thickened walls) warrant surgical intervention.

Question 1

Which of the following is best for the localization of Zollinger-Ellison syndrome?

Accepted Answer

Endoscopic ultrasound (EUS)

Answer

Secretin injection test

Answer

Magnetic resonance imaging (MRI)

Answer

Basal gastric acid output

Question 2

A 45-year-old female presents with recurrent epigastric abdominal pain and jaundice. Ultrasound shows clusters of cysts with lobulated margins in the head of the pancreas. MRI reveals a multicystic mass with a "bunch of grapes" appearance and a grossly dilated pancreatic duct. What is the most probable diagnosis?

Accepted Answer

Intraductal papillary mucinous neoplasm (IPMN)

Answer

Serous cystadenoma

Answer

Mucinous cystadenoma

Answer

Solid pseudopapillary epithelial neoplasm

Question 3

What is the primary diagnostic investigation for carcinoma of the pancreas?

Accepted Answer

MDCT (Multidetector Computed Tomography)

Answer

PET scan (Positron Emission Tomography scan)

Answer

ERCP (Endoscopic Retrograde Cholangiopancreatography)

Answer

MRCP (Magnetic Resonance Cholangiopancreatography)

Question 4

Which of the following are the imaging criteria for unresectable carcinoma of the pancreas?

Accepted Answer

All the above

Answer

Metastatic spread to vertebrae

Answer

Invasion in the duodenal wall

Answer

Irregular increase in density of omental fat

Question 5

What is a pseudopancreatic cyst?

Accepted Answer

A cyst that develops following inflammation

Answer

A cyst that occurs after trauma

Answer

A cyst present from birth

Answer

A cyst that is a tumor

Question 6

What is the best prognosis for carcinoma of the pancreas?

Accepted Answer

Periampullary

Answer

Head

Answer

Tail

Answer

Body

Question 7

Which of the following does NOT correlate with the severity of acute pancreatitis?

Accepted Answer

Serum amylase

Answer

Serum glucose

Answer

Serum calcium

Answer

AST

Question 8

Which of the following is not a contraindication for resection of the head of the pancreas?

Accepted Answer

Ascites

Answer

Liver metastasis

Answer

Peritoneal seedings

Answer

Involvement of a major artery

Question 9

Which of the following statements is FALSE regarding intraductal papillary mucinous neoplasm?

Accepted Answer

Treatment involves the Beger's procedure.

Answer

CEA is often raised.

Answer

Amylase can be raised.

Answer

It occurs equally in both males and females.

Question 10

Which of the following features favors pancreatic adenocarcinoma over non-functioning pancreatic neuroendocrine tumors (NF PET)?

Accepted Answer

Presence of calcifications

Answer

Tumor size <5cm

Answer

Negative chromogranin A

Answer

Negative somatostatin receptor scintigraphy

Pancreatic Surgery — MCQs

Pancreatic Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?